RelayPro Thoracic Stent-Graft System 28-N4-32-209-28URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00843576151055), received between Feb 12, 2025 and Apr 30, 2025 — classified as 1 death, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Advance” (1 report).
2 FDA recall records name this device's identifier, 2 still open.
1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Apr 22, 2026Class IOpen, Classified
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
- Dec 20, 2022Class IIOpen, Classified
The product may be shorter than packaging indicates
Z-0998-2023 · Root cause: Labeling Change Control · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Advance1
- Failure to Advance1
- Insufficient Device Problem Information1
- Mechanical Problem1
Patient problems
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
- Reduced Blood Flow1
- Vascular Dissection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathApr 30, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
"DEATH: ON (B)(6), AN EMERGENCY TEVAR WAS PERFORMED FOR AN AORTIC DISSECTION. THE RELAY PRO STENT GRAFT CONCERNED (28-N4-32-209-28U, LOT#: 2404170130) WAS IMPLANTED CENTRALLY AND A RELAY PRO STENT GRAFT (28-N4-32-164-28U, LOT#: 2407130037) WAS ADDITIONALLY IMPLANTED PERIPHERALLY. THE PROCEDURE WAS COMPLETED WITHOUT ANY PROBLEMS WITH THE PROCEDURE OR THE DEVICES THEMSELVES. ON (B)(6), THE PATIENT'S CONDITION SUDDENLY CHANGED, AND THE PATIENT DIED. AFTER DEATH, A CT SCAN REVEALED THAT THE INTERNAL PRESSURE IN THE FALSE LUMEN HAD INCREASED DUE TO THE EXPANSION OF THE TRUE LUMEN CAUSED BY THE IMPLANTATION OF THE STENT GRAFTS, AND THE FALSE LUMEN HAD RUPTURED AROUND THE ABDOMEN. PHYSICIAN'S COMMENT: THE PHYSICIAN DID THE BEST THAT HE COULD WITH THE MEANS AVAILABLE TO THE HOSPITAL. THERE WAS NO OTHER CHOICE. PHYSICIAN'S COMMENT ON CAUSAL RELATIONSHIP: THE MEANS TAKEN FOR THE AORTIC DISSECTION WERE THE BEST, GIVEN THE EMERGENCY TREATMENT ON (B)(6), BUT THE TRUE LUMEN EXPANDED MORE THAN EXPECTED. OPERATION TYPE: EMERGENCY TEVAR FOR AN AORTIC DISSECTION, NO BLOOD LOSS, ANCILLARY DEVICE USED: 28-N4-32-164-28U (LOT#: 2407130037), NO IMAGE AVAILABLE DUE TO HOSPITAL POLICY, NO PRE-CASE PLAN AVA
Patient problems: Reduced Blood Flow; Vascular Dissection
MAUDE report 21935240 ↗MalfunctionFeb 12, 2025Mechanical Problem; Failure to Advance; Difficult to Advance; Mechanical Problem; Failure to Advance; Difficult to Advance
"WE ADVANCED THE INNER SHEATH IN POSITION ONE USING THE MECHANICAL ADVANTAGE, THE DISENGAGEMENT BUTTON WAS PRESSED AND THE MECHANICAL ADVANTAGE HANDLE ADVANCED FORWARD TO REMOVE THE INNER SHEATH AND DEVICE FROM THE OUTER SHEATH. THE MECHANICAL ADVANTAGE WAS ADVANCED AS FAR AS IT COULD GO, HOWEVER, THE DISTAL 15MM OF THE DEVICE WAS STILL INSIDE THE OUTER SHEATH. WE TRIED TURNING THE MECHANICAL ADVANTAGE TO ADVANCE THE DEVICE THE REST OF THE WAY, BUT IT WOULD NOT ADVANCE AND REMAINED INSIDE THE OUTER SHEATH. WE PULLED AND ADVANCED THE ENTIRE DELIVERY SYSTEM AND THAT ALLOWED THE DEVICE TO EXIT THE OUTER SHEATH, BUT ONLY BY A COUPLE MM'S. AT THAT POINT, WE WENT TURNED TO POSITION TWO, IT TOOK SEVERAL TURNS BEFORE THE INNER SHEATH BEGAN TO MOVE AND DEPLOY THE DEVICE. WHEN IT DID START TO MOVE, IT QUICKLY OPENED THE PROXIMAL END OF THE DEVICE. WE FULLY DEPLOYED THE REST OF THE DEVICE AND POSITION 3 AND 4 OPERATED NORMALLY." PATIENT OUTCOME : "NO CONSEQUENCE TO PATIENT, DEVICE STILL DEPLOYED IN THE INTENDED LOCATION. "
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 21370604 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page